Thompson J - Search Results

1

Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy.

Haanen J, Ernstoff M, Wang Y, Menzies A, Puzanov I, Grivas P, Larkin J, Peters S, Thompson J, Obeid M. Haanen J, et al. Among authors: thompson j. J Immunother Cancer. 2020 Jun;8(1):e000604. doi: 10.1136/jitc-2020-000604. J Immunother Cancer. 2020. PMID: 32532839 Free PMC article. Review.

2

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.

Zou F, Faleck D, Thomas A, Harris J, Satish D, Wang X, Charabaty A, Ernstoff MS, Glitza Oliva IC, Hanauer S, McQuade J, Obeid M, Shah A, Richards DM, Sharon E, Wolchok J, Thompson J, Wang Y. Zou F, et al. Among authors: thompson j. J Immunother Cancer. 2021 Nov;9(11):e003277. doi: 10.1136/jitc-2021-003277. J Immunother Cancer. 2021. PMID: 34789551 Free PMC article.

3

Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol.

Dieng M, Khanna N, Nguyen MTH, Turner R, Lord SJ, Menzies AM, Allen J, Saw R, Nieweg OE, Thompson J, Morton RL. Dieng M, et al. Among authors: thompson j. BMJ Open. 2020 Nov 5;10(11):e037857. doi: 10.1136/bmjopen-2020-037857. BMJ Open. 2020. PMID: 33154047 Free PMC article.

4

Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.

Zenklusen JC, Thompson JC, Klein-Szanto AJ, Conti CJ. Zenklusen JC, et al. Among authors: thompson jc. Cancer Res. 1995 Mar 15;55(6):1347-50. Cancer Res. 1995. PMID: 7882334

5

Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.

Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Zenklusen JC, et al. Among authors: thompson jc. Cancer Res. 1994 Dec 15;54(24):6370-3. Cancer Res. 1994. PMID: 7987830

6

The Immune Landscape of Cancer.

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network; Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I. Thorsson V, et al. Immunity. 2018 Apr 17;48(4):812-830.e14. doi: 10.1016/j.immuni.2018.03.023. Epub 2018 Apr 5. Immunity. 2018. PMID: 29628290 Free PMC article.

7

Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy.

Moncrieff M, Shannon K, Hong A, Hersey P, Thompson J. Moncrieff M, et al. Among authors: thompson j. Melanoma Res. 2008 Apr;18(2):161-2. doi: 10.1097/CMR.0b013e3282f3d117. Melanoma Res. 2008. PMID: 18337654

8

Sentinel node biopsy should be the standard of care for patients with intermediate and thick melanomas.

Spillane A, Read R, Thompson J. Spillane A, et al. Among authors: thompson j. Aust Fam Physician. 2015 Aug;44(8):604-6. Aust Fam Physician. 2015. PMID: 26510152 Free article. No abstract available.

9

Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma.

Wilmott J, Haydu L, Bagot M, Zhang Y, Jakrot V, McCarthy S, Lugassy C, Thompson J, Scolyer R, Barnhill R. Wilmott J, et al. Among authors: thompson j. Histopathology. 2012 Nov;61(5):889-98. doi: 10.1111/j.1365-2559.2012.04279.x. Epub 2012 Jun 20. Histopathology. 2012. PMID: 22716270

10

Correct identification of a sentinel node postselective lymphadenectomy using antimony levels.

Moncrieff M, Scolyer R, Thompson J, Beavis A, Uren R, Stretch J. Moncrieff M, et al. Among authors: thompson j. Melanoma Res. 2008 Oct;18(5):365-6. doi: 10.1097/CMR.0b013e328307bf2d. Melanoma Res. 2008. PMID: 18781136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,865 results

Search Page